Dayan, Gustavo H <br/><br/>
Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil.  [electronic resource] 

 -  The American journal of tropical medicine and hygiene  Dec 2013 
 - 1058-1065 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-1645 
<br/><br/><label>Standard No.: </label>10.4269/ajtmh.13-0304  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antibodies, Neutralizing--blood<br/>Antibodies, Viral--blood<br/>Brazil<br/>Child<br/>Cohort Studies<br/>Dengue--immunology<br/>Dengue Vaccines--administration & dosage<br/>Dengue Virus--immunology<br/>Female<br/>Headache<br/>Humans<br/>Injections, Subcutaneous--adverse effects<br/>Male<br/>Single-Blind Method<br/>Vaccination<br/>Vaccines, Synthetic--administration & dosage